1.5 Abstract in rivista

1.5 Abstract in rivista: [1775] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.061 a 1.080 di 1.775

Bovine to porcine intrathymic islet xenotransplantation

1996-01-01 Del Guerra, S.; Giannarelli, R.; Coppelli, A.; Tellini, C.; Marchetti, P.; Lupi, R.; Carmellini, M.; Viacava, P.; Mosca, F.; Navalesi, R.

Similar insulinotropic effects of alfa- and beta-D-glucose on large mammal and human isolated pancreatic islets

1996-01-01 Lupi, R.; Marchetti, P.; Tellini, C.; Coppelli, A.; Delguerra, S.; Giannarelli, R.; Masiello, P.; Carmellini, M.; Mosca, F.; Navalesi, R.

Cytokine release during co-culture of human lymphomononuclear cells with fresh or cultured allo- or xenoislets

1996-01-01 Giannarelli, R.; Marchetti, P.; Ferdeghini, M.; Arvia, C.; Tellini, C.; Coppelli, A.; Delguerra, S.; Lupi, R.; Consolini, R.; Prontera, C.; Carmellini, M.; Mosca, F.; Navalesi, R.

Exposure to glucagon impairs isolated human islet function. Possible role in islet graft failure?

1997-01-01 Marchetti, P.; Lorenzetti, M.; Lupi, R.; Tellini, C.; Guerra, S.; Giannarelli, R.; Coppell, i A.; Carmellini, M.; Mosca, F.; Navalesi, R.

Insulin and glucagon release of islets prepared from a type 1 diabetic patient

1998-01-01 Marchetti, P.; Lupi, R.; Del Guerra, S.; Dotta, F.; Lencioni, C.; Anastasi, E.; Marselli, L.; Carmellini, M.; Navalesi, R.

Effects of acute or prolonged exposure to leptin on isolated human islet function

1998-01-01 Lupi, R.; Del Guerra, S.; Maffei, M.; Bertacca, A.; Marselli, L.; Lencioni, C.; Tellini, C.; Carmellini, M.; Mosca, F.; Navalesi, R.; Marchetti, P.

Possible direct protective effect of Th2 and Th3 cytokines on Th1 cytokine-induced functional damage of isolated human islets.

1999-01-01 Marselli, L; Dotta, Francesco; Lupi, R; Santangelo, C; Del Guerra, S; Realacci, M; Carmellini, Mario; Navalesi, R; Marchetti, P.

Lipotoxicity in isolated human islets

1999-01-01 Lupi, R.; Del Guerra, S.; Dotta, F.; Marselli, L.; Santangelo, C.; Carmellini, M.; Realacci, M.; Mosca, F.; Navalesi, R.; Marchetti, P.

Pancreatic transplant function evaluation by Tc-99m-Sestamibi scintigraphy

1999-01-01 Carmellini, M.; Marchetti, P.; Manca, G.; Aragona, M.; Boggi, U.; Fontanelli, D.; Mosca, F.; Bianchi, R.

Hepatocyte grafting as an alternative to liver transplant

2001-01-01 Carraresi, L.; Mora, M.; Lazzeri, M.; Comporti, M.; Carli, A.; Carmellini, M.; Rossini, M.

Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure

2007-01-01 Carmellini, Mario; Collini, A; Ruggieri, Giuliana; Garosi, G; Bernini, M.

Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients

2007-01-01 Barni, R; Cataldo, D; Bonato, V; Collini, A; Ruggieri, Giuliana; De Bartolomeis, C; Nigi, L; Bernini, M; Dotta, Francesco; Carmellini, Mario

Post transplant diabetes mellitus: role of insulin-resistance and pro-inflammatory cytokines in first year post-transplant

2008-01-01 Bonato, V; Cataldo, D; Calabrese, M; Tondi, C; Carmellini, Mario; Dotta, Francesco

Conversion of Stable Kidney Transplant Recipients from a Twice-Daily Everolimus Regimen to a Once-Daily Everolimus Regimen.

2009-01-01 Carmellini, Mario; Bernini, M; Ruggieri, Giuliana; Collini, A.

safe conversion of stable kidney transplant recipients from twice-daily tacrolimus (Prograf) to once-daily modified release tacrolimus (advagraf)

2011-01-01 Carmellini, M.; Ruggieri, G.; Collini, A.

Corelation of everolimus exposure with efficacy and safety outcomes in renal transplant recipeints: 24-month update

2011-01-01 Carmellini, M.; Yaqoob, M.; Pattison, J.; Riad, H.; Wang, Z.; Cornu-Artis, C.; Silva, H. T.

Study Design and Preliminary Results of the Italian Everolimus Registry CERTIC in Kidney Transplant Patients

2012-01-01 Carmellini, Mario; Bertoni, E; Tisone, G.; Cappelli, G.; Colombo, D; Brusa, R; Ponticelli, C.

Renal function in renal transplant recipients after 24 months of immunosuppression with concentrations-controlled everolimus plus reduced cyclosporine exposure: unpdate from the A2309 study

2011-01-01 Carmellini, M.; Pattison, J.; Riad, H.; Yaqoob, M.; Vergara, M.; Witte, S.; Cibrik, D.

Exposure-Response Analysis of Everolimus with Reduced Cyclosporine in Renal Transplant Recipients at 24 Months in a Randomized Trial.

2012-01-01 Shihab, F.; Cibrik, D.; Chan, L.; Carmellini, Mario

Turnover and catabolic sites of recombinant human 125-I-Tumor necrosis factor

1986-01-01 Bocci, V.; Pacini, A.; Pessina, G. P.; Maioli, E.; Naldini, A.

Titolo	Data di pubblicazione	Autore(i)	Abstract
Bovine to porcine intrathymic islet xenotransplantation	1-gen-1996	Del Guerra, S.; Giannarelli, R.; Coppelli, A.; Tellini, C.; Marchetti, P.; Lupi, R.; Carmellini, M.; Viacava, P.; Mosca, F.; Navalesi, R.	-
Similar insulinotropic effects of alfa- and beta-D-glucose on large mammal and human isolated pancreatic islets	1-gen-1996	Lupi, R.; Marchetti, P.; Tellini, C.; Coppelli, A.; Delguerra, S.; Giannarelli, R.; Masiello, P.; Carmellini, M.; Mosca, F.; Navalesi, R.	-
Cytokine release during co-culture of human lymphomononuclear cells with fresh or cultured allo- or xenoislets	1-gen-1996	Giannarelli, R.; Marchetti, P.; Ferdeghini, M.; Arvia, C.; Tellini, C.; Coppelli, A.; Delguerra, S.; Lupi, R.; Consolini, R.; Prontera, C.; Carmellini, M.; Mosca, F.; Navalesi, R.	-
Exposure to glucagon impairs isolated human islet function. Possible role in islet graft failure?	1-gen-1997	Marchetti, P.; Lorenzetti, M.; Lupi, R.; Tellini, C.; Guerra, S.; Giannarelli, R.; Coppell, i A.; Carmellini, M.; Mosca, F.; Navalesi, R.	-
Insulin and glucagon release of islets prepared from a type 1 diabetic patient	1-gen-1998	Marchetti, P.; Lupi, R.; Del Guerra, S.; Dotta, F.; Lencioni, C.; Anastasi, E.; Marselli, L.; Carmellini, M.; Navalesi, R.	-
Effects of acute or prolonged exposure to leptin on isolated human islet function	1-gen-1998	Lupi, R.; Del Guerra, S.; Maffei, M.; Bertacca, A.; Marselli, L.; Lencioni, C.; Tellini, C.; Carmellini, M.; Mosca, F.; Navalesi, R.; Marchetti, P.	-
Possible direct protective effect of Th2 and Th3 cytokines on Th1 cytokine-induced functional damage of isolated human islets.	1-gen-1999	Marselli, L; Dotta, Francesco; Lupi, R; Santangelo, C; Del Guerra, S; Realacci, M; Carmellini, Mario; Navalesi, R; Marchetti, P.	-
Lipotoxicity in isolated human islets	1-gen-1999	Lupi, R.; Del Guerra, S.; Dotta, F.; Marselli, L.; Santangelo, C.; Carmellini, M.; Realacci, M.; Mosca, F.; Navalesi, R.; Marchetti, P.	-
Pancreatic transplant function evaluation by Tc-99m-Sestamibi scintigraphy	1-gen-1999	Carmellini, M.; Marchetti, P.; Manca, G.; Aragona, M.; Boggi, U.; Fontanelli, D.; Mosca, F.; Bianchi, R.	-
Hepatocyte grafting as an alternative to liver transplant	1-gen-2001	Carraresi, L.; Mora, M.; Lazzeri, M.; Comporti, M.; Carli, A.; Carmellini, M.; Rossini, M.	-
Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure	1-gen-2007	Carmellini, Mario; Collini, A; Ruggieri, Giuliana; Garosi, G; Bernini, M.	-
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients	1-gen-2007	Barni, R; Cataldo, D; Bonato, V; Collini, A; Ruggieri, Giuliana; De Bartolomeis, C; Nigi, L; Bernini, M; Dotta, Francesco; Carmellini, Mario	-
Post transplant diabetes mellitus: role of insulin-resistance and pro-inflammatory cytokines in first year post-transplant	1-gen-2008	Bonato, V; Cataldo, D; Calabrese, M; Tondi, C; Carmellini, Mario; Dotta, Francesco	-
Conversion of Stable Kidney Transplant Recipients from a Twice-Daily Everolimus Regimen to a Once-Daily Everolimus Regimen.	1-gen-2009	Carmellini, Mario; Bernini, M; Ruggieri, Giuliana; Collini, A.	-
safe conversion of stable kidney transplant recipients from twice-daily tacrolimus (Prograf) to once-daily modified release tacrolimus (advagraf)	1-gen-2011	Carmellini, M.; Ruggieri, G.; Collini, A.	-
Corelation of everolimus exposure with efficacy and safety outcomes in renal transplant recipeints: 24-month update	1-gen-2011	Carmellini, M.; Yaqoob, M.; Pattison, J.; Riad, H.; Wang, Z.; Cornu-Artis, C.; Silva, H. T.	-
Study Design and Preliminary Results of the Italian Everolimus Registry CERTIC in Kidney Transplant Patients	1-gen-2012	Carmellini, Mario; Bertoni, E; Tisone, G.; Cappelli, G.; Colombo, D; Brusa, R; Ponticelli, C.	-
Renal function in renal transplant recipients after 24 months of immunosuppression with concentrations-controlled everolimus plus reduced cyclosporine exposure: unpdate from the A2309 study	1-gen-2011	Carmellini, M.; Pattison, J.; Riad, H.; Yaqoob, M.; Vergara, M.; Witte, S.; Cibrik, D.	-
Exposure-Response Analysis of Everolimus with Reduced Cyclosporine in Renal Transplant Recipients at 24 Months in a Randomized Trial.	1-gen-2012	Shihab, F.; Cibrik, D.; Chan, L.; Carmellini, Mario	-
Turnover and catabolic sites of recombinant human 125-I-Tumor necrosis factor	1-gen-1986	Bocci, V.; Pacini, A.; Pessina, G. P.; Maioli, E.; Naldini, A.	-

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.061 a 1.080 di 1.775

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext1241
reserved439
open79
internalNetwork13
partially open3